BeStock  
Markets › Compare › CYTK vs AVT

CYTK vs AVT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CYTK · Cytokinetics$62.70 ▼ 4.42%
AVT · Avnet$106.19 ▼ 0.70%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

79114150185220Oct 7, '25Apr 7, '26Oct 5, '26
  • CYTK +4.2%
  • AVT +111.1%

Head to head

MetricCYTKAVT
Price$62.70$106.19
Change today▼ 4.42%▼ 0.70%
Market cap$8.72B$8.72B
Return, 3 months-26.7%+30.9%
Return, year to date-1.3%+123.8%
Return, 1 year+3.4%+106.9%
P/E (TTM)-8.726.5
P/B-50.21.7
P/E percentile vs own 5y––
Dividend yield–1.32%
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)2767
30-day volatility36.1%41.6%
Max drawdown, 1 year-28.1%-16.4%
Trend readStrong downtrendStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CYTK is the largest of the group by market value.
  • AVT has returned the most over the past year.
  • CYTK carries the lowest trailing P/E.
  • CYTK has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top